Verified peer comparison
NextDecade vs Spyre Therapeutics Financial Comparison
Direct answer
NextDecade and Spyre Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free NextDecade email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- NextDecade Revenue
- 0 USD
- Spyre Therapeutics Revenue
- 0 USD
- NextDecade Operating income
- -225,931,000 USD
- Spyre Therapeutics Operating income
- -209,562,000 USD